Login

Journal Image
Current Diabetes Reviews
ISSN (Print): 1573-3998
ISSN (Online): 1875-6417
VOLUME: 10
ISSUE: 1
DOI: 10.2174/1573399810666140217114848      Price:  $58









Role of Endogenous GLP-1 and its Agonists in Osteopenia and Osteoporosis: But We Little Know Until Tried

img
Author(s): Athanasia Papazafiropoulou, Nikolaos Papanas, Stavros Pappas and Efstratios Maltezos
Pages 43-47 (5)
Abstract:
The present brief review looks at the evidence on the role of GLP-1 and its agonists in osteopenia and osteoporosis in type 2 diabetes (T2DM). There is accumulating data to suggest a favourable effect of GLP-1 on bone metabolism. However, most data is from experimental studies, while clinical confirmation is still inadequate. Moreover, little is known on the precise mechanisms underlying these effects. Therefore, we need randomised clinical trials in T2DM patients to learn more on the action of GLP-1 on bone metabolism and its potential clinical implications.
Keywords:
Bone metabolism, fractures, GLP-1, incretins, type 2 diabetes mellitus.
Affiliation:
Diabetes Centre, Third Department of Internal Medicine, General Hospital of Nikaia, Piraeus, Greece.